Abiopharma

News list

Director Seimetz Diane 🟢 acquired 80.0K shares (1 derivative) of Humacyte, Inc. (HUMA) at $1.08 Transaction Date: Jun 11, 2026 | Filing ID: 073610

Full text

News bot June 12, 2026, 9:53 p.m.
🔍 Seimetz Diane (Director)

Company: Humacyte, Inc. (HUMA)

Report Date: 2026-06-11
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 80,000
Detailed Transactions and Holdings:
- Acquired 80,000 shares of Stock Options (right to buy) at $1.08 per share (Derivative)
  Date: 2026-06-11 | Code: A | Expires: 2036-06-11 | equity_swap_involved: 0 | shares_owned_after: 80,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The first 25% of the option becomes exercisable on June 11, 2027, after which 1/48 of the option will become exercisable on the 11th of each month through June 11, 2030.